Table 1 Association of global survival in patients with FLC to clinical and pathological characteristics.
Variable | Survival (months) | P (log rank) |
|---|---|---|
Age | ||
≤ 23 years | 8 ± 2 | 0.013 |
> 23 years | 65 ± 19 | |
Gender | ||
male | 26 ± 6 | 0.646 |
female | 42 ± 27 | |
Surgical | ||
resection | 60 ± 10 | 0.011 |
No resection | 5 ± 2 | |
Surgical border | ||
Positive | 20 ± 5 | 0.06 |
Negative | 65 ± 4 | |
Fever | ||
Present | 67 ± 14 | 0.188 |
Absent | 26 ± 7 | |
Jaundice | ||
Present | 65 ± 19 | 0.345 |
Absent | 26 ± 13 | |
Palpable Mass | ||
Present | 42 ± 33 | |
Absent | 26 ± 14 | 0.84 |
Weight loss | ||
Present | 26 ± 6 | 0.646 |
Absent | 42 ± 27 | |
Ascites | ||
Present | 4 ± 32 | 0.578 |
Absent | 42 ± 2 | |
Hepatomegaly | ||
Present | 42 ± 20 | 0.681 |
Absent | 20 ± 14 | |
Vascular Invasion | ||
Present | 5 ± 2 | .0061 |
Absent | 60 ± 10 | |
Atypia | ||
low | 26 ± 13 | 0.319 |
Moderate | 65 ± 9 | |
Hemoglobin | ||
≤ 12 | 26 ± 19 | 0.527 |
>12 | 42 ± 28 | |
Liver enzymes | ||
abnormal | 26 ± 11 | 0.04 |
normal | 65 ± 21 | |
Alkaline phosphatase | ||
abnormal | 65 ± 44 | 0.682 |
normal | 42 ± 17 | |
Albumin | ||
abnormal | 5 ± 30 | 0.9 |
normal | 42 ± 19 | |
Alfa fetoprotein | ||
abnormal | 20 ± 21 | 0.672 |
normal | 42 ± 21 | |
TNM | ||
Stage I and II | 65 ± 14 | 0.693 |
III | 60 ± 12 | |
IV | 8 ± 8 |